http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9932503-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b9c772e40652eb4231c7cb1ba2bf3ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68509e42daf8668d7e06824f7a480a77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9dcb206d732a0513c4eb5127d1a5e70d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_373743c77991a39219a90816c21c758a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
filingDate 1998-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11fc65d388fe5690cb369e057a4e597f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e7147b12a708b705af1a9e0fb01da44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a7a7ffe13a88aeb71d75530ee4cd543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f09ca75d75fdd35ba7e43b70b379b4fe
publicationDate 1999-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9932503-A1
titleOfInvention Dna pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof
abstract The present invention relates to nucleic acid formulations of pharmaceutical products which comprise citrate and/or triethanolamine in concentrations which enhance stability of the nucleic acid. These formulations are suited for situations where prolonged storage occurs during the distribution and/or storage period prior to use.
priorityDate 1997-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5211960-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4840892-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87060535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127822821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232108843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129382061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69759773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7618
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7427

Total number of triples: 54.